secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Therapeutics, Inc. (VYGR)
CIK:        0001640266
Form:       8-K
Filed at:   2023-07-10T23:59:59+00:00
Accession:  0001104659-23-079340
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Voyager Therapeutics appoints Jacquelyn Fahey Sandell as Chief Legal Officer
----------------------------------------------------------------------------

- Jacquelyn Fahey Sandell named CLO effective July 10, 2023; reports to CEO Alfred Sandrock.
- Base salary of $450,000 per year; eligible for annual cash bonus at 40% of base salary target.
- Inducement equity grant: option to purchase 122,000 shares (4-year vest) and RSU for 61,000 shares (3-year vest).
- Severance includes 12 months base salary, pro-rata target bonus, COBRA subsidy, and full equity acceleration upon qualifying termination within 12 months of a sale event.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1640266/000110465923079340/0001104659-23-079340-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1640266/000110465923079340/tm2320812d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-079340

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer